Get Your FREE Subscription to HQ Magazine!
Canna Aid

1 out of 4 CBD Products is NOT Tested

for Microbial Content, Pesticides, or Heavy Metals 

The CBD industry’s peer-reviewed watchdog Leafreport.com recently undertook an comprehensive review of 2946 products from 136 brands to verify how many were being tested by third-party facilities for purity or potency. The report also released a list of the top ten most transparent brands.

“The CBD industry is still very unregulated,” said Shafir, the head of product at Leafreport. “There have been many cases of companies selling products that contain little to no CBD–that’s why third-party testing is so critical for brands in this industry.”

Pure, Clean CBD? It’s Unlikely: Only 13% of Brands Tested Almost All of Their Products for Purity

‘Clean’, ‘safe’, ‘natural’, or ‘pure’ CBD are pivotal selling points for many CBD brands. However, these buzz words are meaningless without the evidence to support such claims.

One of the key findings of the report was that only 13% of CBD companies tested almost all of their products for detectable levels of contaminants such as heavy metals, pesticides, or microbial content. But 25% didn’t test any of their products for purity at all.

“We were stunned to find that of the big-name brands we reviewed, one in four didn’t test any of their products for the presence of contaminants,” said Shafir. “It’s particularly concerning given that hemp, from which CBD is extracted, is a phyto-remedial plant that absorbs toxins and heavy metals from the soil”.

Do Most CBD Products Deliver the Promised Potency? Don’t Bet on It–84% Don’t Measure within the Acceptable Variance

Among other key findings exposed by the report were significant discrepancies between the product’s labelled potency compared with the contents of the bottle.

The concentration of CBD stated on a product label must match the concentration measured by the testing laboratory within a 10% variance, which means that a high-quality CBD product is expected to have CBD levels that are within 90–110% of what is advertised.

84% of the 2946 products tested were found to be outside the limits of acceptable variance. Leafreport also uncovered that only 42% of brands tested all their products for potency.

“The number of brands sidestepping third-party potency testing, or testing outside the allowable variance, is a genuine source of concern,” commented Shafir.

“Testing to ensure the potency of your product is accurate is a fundamental aspect of brand integrity–especially in the case of CBD products that are frequently used as medicine. Children diagnosed with rare forms of pediatric epilepsy use CBD to help control seizures, so it’s absolutely essential that their caregivers know what’s in the bottle to get dosage right.”

Less is More: Brands with Fewer than 8 Products are More Likely to Test for Both Purity and Potency

Another telling finding revealed by the report was that brands offering 7 products or less were more likely to test most of their products for both potency and purity, as opposed to brands with over 40 products. These results suggest that third-party testing may be more manageable, and financially practicable, for brands with fewer products.

It’s Time for CBD Brands to Level Up and Become More Accountable

Overall, the findings of the report indicate that vast discrepancies and unknowns characterize what consumers believe they are purchasing–and the actual contents of the CBD product.

“The excitement generated by CBD has led to the explosion of largely unregulated industry that must become more accountable to consumers,” reflected Shafir.

Transparency report summary

 

http://d1h.7b5.myftpupload.com/industry-insights/1-out-of-4-cbd-products-is-not-tested/?fbclid=IwAR0ih9_—UVMaK3xssQ6gXX17GwuP4fDbbXSRKDVZMz0krJ7UKUkkIpUf4

 

 

Recent Articles

Academic institutions have designed courses, certificate programs, and degrees to equip students with cannabis industry knowledge, but many live in fear of a shutdown.
Taking advantage of the benefits of vaping is just a matter of knowing about the types of processes and products available to consumers.
Have you ever wondered what happened to the idealism of the 1960s? It died . . . alongside cannabis activist Dana Beal. Luckily, they’re both back now.
There’s something about small companies. They move fast. They innovate. They provide god-tier customer service. Okay, maybe that’s not true for all small companies. But it is for Purr Glass.
Rebecca Abraham is yet another extraordinary human facing another heroic task. A nurse by trade—and more importantly, by inclination —Abraham is working to convince the relatively conservative American medical community that cannabis does indeed have a role to play in clinical practice.
Luckily, cannabis rules are much more lax now due to collective bargaining agreements and players’ unions. Now, in all major professional sports leagues, players who test positive for marijuana cannot be suspended, although they can face fines and mandatory treatment programs.